James L. Tyree - 20 May 2021 Form 4 Insider Report for ChemoCentryx, Inc.

Role: Director
Signature: /s/ Susan M. Kanaya, as Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 20 May 2021
Net transactions value: -$23,956
Form type: 4
Filing time: 24 May 2021, 20:19:39 UTC
Previous filing: 13 May 2021
Next filing: 21 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CCXI	Common Stock	Options Exercise	$0	+4,660	+36%	$0.000000	17,729	21 May 2021	Direct	F1
transaction	CCXI	Common Stock	Sale	$23,956	-2,454	-14%	$9.76	15,275	21 May 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCXI	Restricted Stock Units	Award		+7,726			7,726	20 May 2021	Common Stock	7,726		Direct	F4, F5
transaction	CCXI	Stock Option (right to buy)	Award		+4,504			4,504	20 May 2021	Common Stock	4,504	$10.06	Direct	F6, F7
transaction	CCXI	Restricted Stock Units	Options Exercise		-4,660	-100%		0	21 May 2021	Common Stock	4,660		Direct	F4, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired upon vesting of restricted stock units awarded on May 21, 2020.
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover anticipated taxes due upon vesting of restricted stock unit shares.
F3	Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.65 to $10.03 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F4	Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
F5	The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
F6	The option granted on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.
F7	Not applicable.
F8	100% of the restricted stock units vested on May 21, 2021. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.